Cargando…

Immune response to SARS-CoV-2 infection and vaccination in patients receiving kidney replacement therapy

In this issue of Kidney International, the initial experience regarding the immunogenicity of prior coronavirus disease 2019 (COVID-19) infection and the response to the COVID-19 vaccines among patients on maintenance dialysis and kidney transplant recipients is summarized. Preliminary data suggest...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ikizler, T. Alp, Coates, P. Toby, Rovin, Brad H., Ronco, Pierre
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Society of Nephrology. Published by Elsevier Inc. 2021
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8055920/ https://www.ncbi.nlm.nih.gov/pubmed/33931226 http://dx.doi.org/10.1016/j.kint.2021.04.007

Ejemplares similares

Early experience with COVID-19 in kidney transplantation
por: Coates, P. Toby, et al.
Publicado: (2020)

Acute kidney injury in SARS-CoV-2 infected patients
por: Fanelli, Vito, et al.
Publicado: (2020)

Kidney International and the COVID-19 infection
por: Rovin, Brad H., et al.
Publicado: (2020)

Safety of Low-Protein Diets and Ketoanalogue Supplementation in CKD
por: Ikizler, T. Alp
Publicado: (2018)

Immunologic Responses After COVID-19 Vaccination in Patients With Membranous Nephropathy Receiving Anti–CD38 Felzartamab Therapy: Results From the Phase 1b/2a M-PLACE Study
por: Rovin, Brad H., et al.
Publicado: (2022)

A Kidney International “journal of the COVID-19 year” in kidney transplantation
por: Coates, P. Toby
Publicado: (2020)

COVID-19 vaccination followed by activation of glomerular diseases: does association equal causation?
por: Li, Nicholas L., et al.
Publicado: (2021)

The COVID-19 infection in dialysis: are home-based renal replacement therapies a way to improve patient management?
por: Cozzolino, Mario, et al.
Publicado: (2020)

SARS-CoV-2 vaccination for immune-comprised patients: More is required
por: Li, Hui, et al.
Publicado: (2021)

Is It Time to Reconsider How We Initiate Maintenance Dialysis?
por: Arellano-Mendez, Denisse, et al.
Publicado: (2022)

Platelet size as a mirror for the immune response after SARS‐CoV‐2 vaccination
por: Thiele, Thomas, et al.
Publicado: (2022)

Recent evolution of renal replacement therapy in the critically ill patient
por: Ronco, Claudio
Publicado: (2006)

Timely development of vaccines against SARS-CoV-2
por: Lu, Shan
Publicado: (2020)

Inactivated SARS-CoV-2 vaccine for people with HIV
por: Wolday, Dawit, et al.
Publicado: (2022)

Is there a post-SARS-CoV-2 vaccination dementia?
por: Fiorini, Ana C., et al.
Publicado: (2022)

The role of multiple SARS-CoV-2 viral antigens in a vaccine-induced integrated immune response
por: Zhang, Ying, et al.
Publicado: (2021)

IgM responses following SARS-CoV-2 vaccination: insights into protective and pre-existing immunity
por: Fraussen, Judith
Publicado: (2022)

Unanticipated efficacy of SARS-CoV-2 vaccination in older adults
por: Pawelec, Graham, et al.
Publicado: (2021)

Multicomponent vaccines to fight SARS-CoV-2 variants of concern
por: Cassone, Antonio, et al.
Publicado: (2021)

The challenge of emerging SARS-CoV-2 mutants to vaccine development
por: Li, Rong, et al.
Publicado: (2021)

SARS-CoV-2 immunogenicity: Is S protein the best target for vaccination?
por: Antonopoulou, Tania, et al.
Publicado: (2022)

Questioning the justification for a fourth SARS-CoV-2 vaccine
por: Calderon-Margalit, Ronit, et al.
Publicado: (2022)

Mucosal immunity to SARS-CoV-2: a clinically relevant key to deciphering natural and vaccine-induced defences
por: Matuchansky, Claude
Publicado: (2021)

Implementing digital passports for SARS-CoV-2 immunization in Canada
por: Wilson, Kumanan, et al.
Publicado: (2021)

A framework for monitoring population immunity to SARS-CoV-2
por: Lopman, Benjamin A., et al.
Publicado: (2021)

Immune Response Post–SARS-CoV-2 mRNA Vaccination in Kidney Transplant Recipients Receiving Belatacept
por: Noble, Johan, et al.
Publicado: (2021)

SARS-CoV-2 SPIKE PROTEIN: an optimal immunological target for vaccines
por: Salvatori, Giovanni, et al.
Publicado: (2020)

Pregnant people deserve the protection offered by SARS-CoV-2 vaccines
por: Maykin, Melanie M., et al.
Publicado: (2021)

Positive aspects of the mRNA platform for SARS-CoV-2 vaccines
por: Hajissa, Khalid, et al.
Publicado: (2021)

COVID-19 vaccines: Keeping pace with SARS-CoV-2 variants
por: Cevik, Muge, et al.
Publicado: (2021)

Acute Kidney Injury in SARS-CoV-2 Infection: Direct Effect of Virus on Kidney Proximal Tubule Cells
por: Soleimani, Manoocher
Publicado: (2020)

T cells as the hoped-for savior for SARS-CoV-2 vaccination during CD20-depleting antibody therapy?: Commentary for: “Discordant humoral and T cell immune responses to SARS-CoV-2 vaccination in people with multiple sclerosis on anti-CD20 therapy.”
por: Bsteh, Gabriel, et al.
Publicado: (2021)

The paramount importance of serological surveys of SARS-CoV-2 infection and immunity
por: Goudsmit, Jaap
Publicado: (2020)

Acute exercise and immune response in previously SARS CoV-2 infection
por: Sookaromdee, Pathum, et al.
Publicado: (2021)

Protein vaccine NVX-CoV2373 elicits functional T cell immunity
por: Zhou, Pengcheng
Publicado: (2022)

Acute kidney stress—a useful term based on evolution in the understanding of acute kidney injury
por: Katz, Nevin, et al.
Publicado: (2016)

Factors Influencing Longevity of Humoral Response to SARS-CoV-2 Vaccination in Patients with End Stage Kidney Disease Receiving Renal Replacement Therapy
por: Glowinska, Irena, et al.
Publicado: (2022)

Skin rashes after SARS‐CoV‐2 vaccine: which relationship, if any?
por: Patruno, Cataldo, et al.
Publicado: (2021)

Vaccine against SARS-CoV-2 in previously infected health care workers
por: Parisi, Saverio Giuseppe
Publicado: (2021)

Increasing SARS-CoV-2 vaccination rates among Black people in Canada
por: Eissa, Azza, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7s87rndh9h53h3gap0ebu8sren